Abstract submission is NOW OPEN through Jan. 31, 2025! Send us your research for possible presentation at the 28th Annual Meeting!
Nominate yourself or a colleague by September 16 for one of ASGCT's prestegious Annual Meeting honors by emailing your nomination letters to awards@asgct.org. See the full list below for all ASGCT Annual Meeting award opportunities.
The ASGCT Outstanding Achievement Award recognizes an ASGCT member who has achieved a pioneering research success, a specific high impact accomplishment, or a lifetime of significant contributions to the field of gene and cell therapy. It is the Society’s highest honor.
Several Outstanding New Investigators are recognized each year based on their contributions to the field of gene and cell therapy. Investigators from academia, research foundations, government, and industry are all eligible to be nominated for awards.
This honorific award recognizes individuals for their outstanding contributions toward the mentorship, training, education, or support of students, residents, fellows, trainees, or other early career professionals either through formal training programs or through non-traditional means.
Named for the first person to study viral mediated gene therapy for muscular dystrophy in humans, and the principal investigator in the study that led to the FDA approval of Zolgensma to treat SMA, the Jerry Mendell Award for Translational Science recognizes the extensive work required to bring gene and cell therapies to clinical trial.
Named for its inaugural co-recipient and tireless gene therapy advocate, the Society’s Sonia Skarlatos Public Service Award recognizes a person or group that has consistently fostered and enhanced the field of gene and cell therapy through governmental agencies, public policy groups, public education, or non-governmental charitable organizations.
The ASGCT Catalyst Award recognizes an ASGCT member or team of professionals who have had an extraordinary impact on the translation of gene and cell therapies.
Established in 2022, the ASGCT Founders Award recognizes a pioneering contributor to the gene and cell therapy field. It is among the Society’s highest honors and the recipient presents a keynote lecture highlighting their accomplishments that led to the award.
This award highlights the contribution of a lead author under the age of 40 to the Molecular Therapy family of journals.
This honorific award recognizes individuals, organizations, or other entities for their outstanding contributions toward the Society’s principles and programs advancing diversity, equity, and inclusion.
This honorific award recognizes individuals for their outstanding contributions to ASGCT and their commitment to Society’s mission to advance knowledge, education, and awareness of gene and cell therapy.
ASGCT supports the travel of approximately 150 Associate Members each year through the Meritorious Abstract Travel Award program. Recipients will receive a certificate and a travel reimbursement stipend of up to $500 for domestic awardees and $600 for international awardees to the Annual Meeting.
Each year the ASGCT Abstract Review Committee for the Annual Meeting selects the top six abstracts submitted by students and fellows to receive Excellence in Research Awards.
The top poster presentations from each of the three poster sessions that occur during the ASGCT Annual Meeting are awarded Outstanding Poster Presentation Awards.
First introduced in 2016, the ASGCT Underrepresented Minority Travel Awards honor and support ASGCT Associate Members who submitted abstracts to the Annual Meeting.
November 19-20, 2024 | Chicago, IL
© 2000-2024 All rights reserved. American Society of Gene & Cell Therapy.
Kentico CMS Development by Reason One | Powered by Kentico